13-45465145-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP5BP4
The NM_031431.4(COG3):āc.109G>Cā(p.Asp37His) variant causes a missense change. The variant allele was found at a frequency of 0.0000297 in 1,613,482 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Genomes: š 0.000013 ( 0 hom., cov: 33)
Exomes š: 0.000031 ( 0 hom. )
Consequence
COG3
NM_031431.4 missense
NM_031431.4 missense
Scores
7
12
Clinical Significance
Conservation
PhyloP100: 5.12
Genes affected
COG3 (HGNC:18619): (component of oligomeric golgi complex 3) This gene encodes a component of the conserved oligomeric Golgi (COG) complex which is composed of eight different subunits and is required for normal Golgi morphology and localization. Defects in the COG complex result in multiple deficiencies in protein glycosylation. The protein encoded by this gene is involved in ER-Golgi transport.[provided by RefSeq, Jun 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 13-45465145-G-C is Pathogenic according to our data. Variant chr13-45465145-G-C is described in ClinVar as [Pathogenic]. Clinvar id is 2584760.Status of the report is no_assertion_criteria_provided, 0 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.16596475). . Strength limited to SUPPORTING due to the PP5.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
COG3 | NM_031431.4 | c.109G>C | p.Asp37His | missense_variant | 1/23 | ENST00000349995.10 | |
COG3 | XM_047430702.1 | c.109G>C | p.Asp37His | missense_variant | 1/19 | ||
COG3 | XR_007063702.1 | n.207G>C | non_coding_transcript_exon_variant | 1/14 | |||
COG3 | XR_429222.5 | n.207G>C | non_coding_transcript_exon_variant | 1/24 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
COG3 | ENST00000349995.10 | c.109G>C | p.Asp37His | missense_variant | 1/23 | 1 | NM_031431.4 | P1 | |
COG3 | ENST00000617493.1 | c.109G>C | p.Asp37His | missense_variant | 1/12 | 1 | |||
COG3 | ENST00000476702.1 | c.82G>C | p.Asp28His | missense_variant | 1/2 | 3 | |||
COG3 | ENST00000617325.1 | n.248G>C | non_coding_transcript_exon_variant | 1/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152236Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
2
AN:
152236
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000656 AC: 16AN: 244026Hom.: 0 AF XY: 0.0000752 AC XY: 10AN XY: 133054
GnomAD3 exomes
AF:
AC:
16
AN:
244026
Hom.:
AF XY:
AC XY:
10
AN XY:
133054
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461128Hom.: 0 Cov.: 30 AF XY: 0.0000371 AC XY: 27AN XY: 726894
GnomAD4 exome
AF:
AC:
46
AN:
1461128
Hom.:
Cov.:
30
AF XY:
AC XY:
27
AN XY:
726894
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152354Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74500
GnomAD4 genome
AF:
AC:
2
AN:
152354
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74500
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
8
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Congenital disorder of glycosylation, type IIbb Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 19, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.
REVEL
Benign
Sift
Benign
T;.
Sift4G
Uncertain
T;D
Polyphen
P;D
Vest4
MutPred
Gain of catalytic residue at D37 (P = 0.0779);Gain of catalytic residue at D37 (P = 0.0779);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at